Chemed (CHE) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $515.44, +0.44% vs the prior close of $513.18.
- Volume 139.10K shares, 0.9x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
CHE rises 0.4% to $515.44, a 1-month high, 5 up days in a row. Closed at $515.44, +0.44% vs the prior close of $513.18. Day range $508.99–$519.64, opened at $519.64.
CHE daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — CHE rises 0.4% to $515.44, a 1-month high, 5 up days in a row
- Closed at $515.44, +0.44% vs the prior close of $513.18. Day range $508.99–$519.64, opened at $519.64.
- Volume was 139.10K shares, 0.9x its 50-day average of 150.54K.
- Price is -0.7% vs its 50-day average ($518.96) and +12.4% vs its 200-day average ($458.40).
- 52-week range $365.21–$557.00; today's close sits at 78% of that range, 7.5% below the 52-week high.
- That makes 5 straight gains.
Oct 14, 2026 — CHE rises 2.5% to $513.18, 4 up days in a row
- Closed at $513.18, +2.48% vs the prior close of $500.77. Day range $500.89–$513.93, opened at $500.89.
- Volume was 129.90K shares, 0.8x its 50-day average of 152.90K.
- Price is -1.2% vs its 50-day average ($519.58) and +12.0% vs its 200-day average ($457.99).
- 52-week range $365.21–$557.00; today's close sits at 77% of that range, 7.9% below the 52-week high.
- That makes 4 straight gains.
Oct 13, 2026 — CHE ends flat (+0.0%) to $500.77, 3 up days in a row
- Closed at $500.77, +0.03% vs the prior close of $500.64. Day range $496.79–$505.89, opened at $504.83.
- Volume was 104.60K shares, 0.7x its 50-day average of 154.61K.
- Price is -3.7% vs its 50-day average ($520.12) and +9.4% vs its 200-day average ($457.59).
- 52-week range $365.21–$557.00; today's close sits at 71% of that range, 10.1% below the 52-week high.
- That makes 3 straight gains.
Oct 12, 2026 — CHE ends flat (+0.2%) to $500.64
- Closed at $500.64, +0.16% vs the prior close of $499.82. Day range $499.57–$505.87, opened at $501.76.
- Volume was 119.70K shares, 0.8x its 50-day average of 156.65K.
- Price is -3.9% vs its 50-day average ($520.91) and +9.5% vs its 200-day average ($457.26).
- 52-week range $365.21–$557.00; today's close sits at 71% of that range, 10.1% below the 52-week high.
Oct 9, 2026 — CHE rises 0.3% to $499.82
- Closed at $499.82, +0.32% vs the prior close of $498.25. Day range $493.43–$502.15, opened at $497.65.
- Volume was 134.50K shares, 0.9x its 50-day average of 157.24K.
- Price is -4.2% vs its 50-day average ($521.54) and +9.4% vs its 200-day average ($456.92).
- 52-week range $365.21–$557.00; today's close sits at 70% of that range, 10.3% below the 52-week high.
Oct 8, 2026 — CHE dips 0.6% to $498.25, 3 down days in a row
- Closed at $498.25, -0.64% vs the prior close of $501.45. Day range $494.12–$499.73, opened at $495.65.
- Volume was 135.50K shares, 0.8x its 50-day average of 160.25K.
- Price is -4.6% vs its 50-day average ($522.24) and +9.1% vs its 200-day average ($456.60).
- 52-week range $365.21–$557.00; today's close sits at 69% of that range, 10.5% below the 52-week high.
- That makes 3 straight losses.
Oct 7, 2026 — CHE dips 1.6% to $501.45
- Closed at $501.45, -1.65% vs the prior close of $509.84. Day range $499.52–$514.67, opened at $508.32.
- Volume was 139.10K shares, 0.9x its 50-day average of 161.43K.
- Price is -4.1% vs its 50-day average ($523.07) and +9.9% vs its 200-day average ($456.29).
- 52-week range $365.21–$557.00; today's close sits at 71% of that range, 10.0% below the 52-week high.
Oct 6, 2026 — CHE ends flat (-0.3%) to $509.84
- Closed at $509.84, -0.29% vs the prior close of $511.30. Day range $506.32–$517.98, opened at $513.77.
- Volume was 129.20K shares, 0.8x its 50-day average of 162.12K.
- Price is -2.6% vs its 50-day average ($523.39) and +11.8% vs its 200-day average ($455.93).
- 52-week range $365.21–$557.00; today's close sits at 75% of that range, 8.5% below the 52-week high.
Oct 5, 2026 — CHE rises 0.7% to $511.30
- Closed at $511.30, +0.75% vs the prior close of $507.50. Day range $500.97–$514.46, opened at $505.75.
- Volume was 138.60K shares, 0.9x its 50-day average of 161.63K.
- Price is -2.3% vs its 50-day average ($523.38) and +12.2% vs its 200-day average ($455.54).
- 52-week range $365.21–$557.00; today's close sits at 76% of that range, 8.2% below the 52-week high.
Oct 2, 2026 — CHE rises 0.9% to $507.50
- Closed at $507.50, +0.91% vs the prior close of $502.90. Day range $499.64–$510.82, opened at $502.88.
- Volume was 159.10K shares, 1.0x its 50-day average of 160.66K.
- Price is -3.0% vs its 50-day average ($523.38) and +11.5% vs its 200-day average ($455.13).
- 52-week range $365.21–$557.00; today's close sits at 74% of that range, 8.9% below the 52-week high.
CHE latest news & SEC filings
Every SEC filing by or about CHE in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 1, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Lee Spencer S converted options/RSUs into 12,099 shares at $445.35 (≈$5.39M) on Sep 30, 2026; now holds 26,011
- Lee Spencer S had withheld for taxes 11,160 shares at $508.93 (≈$5.68M) on Sep 30, 2026; now holds 14,851
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 30, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Mcnamara Kevin J sold 2,000 shares at $513.45 (≈$1.03M) on Sep 28, 2026; now holds 66,418
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 29, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Hutton Thomas C converted options/RSUs into 4,629 shares at $445.35 (≈$2.06M) on Sep 28, 2026; now holds 37,110
- Hutton Thomas C had withheld for taxes 4,270 shares at $506.65 (≈$2.16M) on Sep 28, 2026; now holds 32,840
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 28, 2026 · 144 — Notice of proposed sale (Form 144)
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Sep 24, 2026 · 144 — Notice of proposed sale (Form 144)
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Sep 21, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Mcnamara Kevin J sold 2,000 shares at $501.40 (≈$1.00M) on Sep 18, 2026; now holds 68,418
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 12, 2026 · SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 31, 2026 · 10-Q — Quarterly report (unaudited financial statements for the quarter)
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $673.25M (prior year $618.80M) (+8.8% vs Jun 30, 2025)
- Net income: $67.70M (prior year $52.49M) (+29.0% vs Jun 30, 2025)
- Diluted EPS: $5.13 (prior year $3.57) (+43.7% vs Jun 30, 2025)
Jul 28, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jun 24, 2026 · 11-K — Annual report for an employee stock plan
Annual report for an employee stock plan
Things to know before you trade CHE
- Last results release: Jul 28, 2026 (8-K Item 2.02). Previous ones: Apr 23, 2026, Feb 25, 2026, Oct 28, 2025. Based on that rhythm, the next report is likely around Oct 27, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 0.81% (largest 3.3%). That is a relatively calm stock.
- Liquidity: about 162.31K shares (≈$83.66M) trade per day on average.
- 52-week position: $515.44 vs a range of $365.21–$557.00 (78% of the range).
- Dividends: last ex-dividend date Aug 17, 2026 ($0.7/share); 4 payments in the past 12 months.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 13 sales; latest: Kevin J Mcnamara sold 2,000 shares on Sep 28, 2026.
- Latest filings: 10-Q Jul 31, 2026; 8-K Jul 28, 2026; 8-K May 19, 2026.
- Share count: 13.07M shares outstanding (Jun 30, 2026), -10.3% vs a year earlier — the company has been reducing its share count.
- Listing: NYSE · industry: Services-Home Health Care Services.
CHE market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 519.64 | 519.64 | 508.99 | 515.44 | 139.10K |
| Oct 14, 2026 | 500.89 | 513.93 | 500.89 | 513.18 | 129.90K |
| Oct 13, 2026 | 504.83 | 505.89 | 496.79 | 500.77 | 104.60K |
| Oct 12, 2026 | 501.76 | 505.87 | 499.57 | 500.64 | 119.70K |
| Oct 9, 2026 | 497.65 | 502.15 | 493.43 | 499.82 | 134.50K |
| Oct 8, 2026 | 495.65 | 499.73 | 494.12 | 498.25 | 135.50K |
| Oct 7, 2026 | 508.32 | 514.67 | 499.52 | 501.45 | 139.10K |
| Oct 6, 2026 | 513.77 | 517.98 | 506.32 | 509.84 | 129.20K |
| Oct 5, 2026 | 505.75 | 514.46 | 500.97 | 511.30 | 138.60K |
| Oct 2, 2026 | 502.88 | 510.82 | 499.64 | 507.50 | 159.10K |
| Oct 1, 2026 | 504.91 | 508.35 | 497.29 | 502.90 | 201.70K |
| Sep 30, 2026 | 512.16 | 514.50 | 503.36 | 505.07 | 155.90K |
| Sep 29, 2026 | 511.34 | 516.82 | 507.47 | 512.05 | 118.30K |
| Sep 28, 2026 | 512.15 | 519.05 | 509.11 | 514.30 | 216.00K |
| Sep 25, 2026 | 503.12 | 514.51 | 498.79 | 512.16 | 233.30K |
| Sep 24, 2026 | 499.19 | 501.46 | 491.88 | 495.65 | 146.20K |
| Sep 23, 2026 | 494.97 | 505.22 | 493.98 | 498.09 | 138.50K |
| Sep 22, 2026 | 500.55 | 505.79 | 495.37 | 496.62 | 131.60K |
| Sep 21, 2026 | 507.79 | 509.59 | 496.97 | 499.62 | 159.30K |
| Sep 18, 2026 | 504.50 | 512.25 | 498.23 | 504.06 | 416.20K |
About Chemed
Chemed (CHE) is listed on the NYSE and classified by the SEC under “Services-Home Health Care Services”. Its business address is in CINCINNATI, OH. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 19584.
CHE board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Ron Delyons | Director | May 19, 2026 |
| Patrick P Grace | Director | Aug 3, 2026 |
| Thomas C Hutton | vice president | Sep 29, 2026 |
| Christopher J Heaney | Director | May 19, 2026 |
| Andrea R Lindell | Director | Jun 10, 2026 |
| Kevin J Mcnamara | president and CEO | Sep 30, 2026 |
| Eileen P Mccarthy | Director | May 19, 2026 |
| John Meredith Jr. Mount | Director | May 19, 2026 |
| George J Iii Walsh | Director | May 29, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Thomas C Hutton | vice president | Sep 29, 2026 |
| Brian C Judkins | VP and Chief Legal Officer | Aug 10, 2026 |
| Spencer S Lee | executive vice president | Aug 24, 2026 |
| Kevin J Mcnamara | president and CEO | Sep 30, 2026 |
| Nicholas Michael Westfall | Executive Vice President | Feb 5, 2026 |
| Joel L Wherley | CEO - Vitas Healthcare | Aug 6, 2026 |
| Michael D Witzeman | VP & Chief Financial Officer | Feb 17, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 28, 2026 | Kevin J Mcnamara | Sale | 2,000 | $513.45 |
| Sep 18, 2026 | Kevin J Mcnamara | Sale | 2,000 | $501.40 |
| Aug 21, 2026 | Kevin J Mcnamara | Sale | 2,000 | $541.16 |
| Aug 21, 2026 | Spencer S Lee | Sale | 1,000 | $541.04 |
| Aug 3, 2026 | Kevin J Mcnamara | Sale | 2,000 | $539.51 |
| Jul 31, 2026 | Patrick P Grace | Sale | 190 | $532.00 |
| Jun 9, 2026 | Andrea R Lindell | Sale | 1,347 | $447.33 |
| May 29, 2026 | George J Iii Walsh | Sale | 500 | $437.83 |
| May 8, 2026 | Patrick P Grace | Sale | 60 | $425.78 |
| May 1, 2026 | Kevin J Mcnamara | Sale | 2,000 | $421.13 |
| Mar 27, 2026 | Kevin J Mcnamara | Sale | 1,500 | $369.37 |
| Mar 12, 2026 | Kevin J Mcnamara | Sale | 2,000 | $403.18 |
| Nov 24, 2025 | Kevin J Mcnamara | Sale | 2,000 | $437.55 |
CHE financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $265.24M | 18.34 | $388.27M |
| Dec 31, 2024 | $1.53B | $302.00M | 19.89 | $417.50M |
| Dec 31, 2023 | $1.32B | $272.51M | 17.93 | $330.30M |
| Dec 31, 2022 | $1.20B | $249.62M | 16.53 | $309.89M |
| Dec 31, 2021 | $1.26B | $268.55M | 16.85 | $308.60M |
Latest balance sheet: total assets $1.58B, total liabilities $749.08M, cash $40.22M (as of Jun 30, 2026).
CHE earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Jul 28, 2026 | 8-K Item 2.02 (results) | $517.63 |
| Apr 23, 2026 | 8-K Item 2.02 (results) | $382.97 |
| Feb 25, 2026 | 8-K Item 2.02 (results) | $466.60 |
| Oct 28, 2025 | 8-K Item 2.02 (results) | $438.94 |
| Jul 29, 2025 | 8-K Item 2.02 (results) | $464.69 |
| Apr 23, 2025 | 8-K Item 2.02 (results) | $585.46 |
| Feb 26, 2025 | 8-K Item 2.02 (results) | $545.79 |
| Oct 29, 2024 | 8-K Item 2.02 (results) | $609.80 |
| Jul 24, 2024 | 8-K Item 2.02 (results) | — |
| Apr 24, 2024 | 8-K Item 2.02 (results) | — |
| Feb 27, 2024 | 8-K Item 2.02 (results) | — |
| Oct 25, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Services-Home Health Care Services
Option Care Health (OPCH)BrightSpring Health Services (BTSG)Aveanna Healthcare (AVAH)Addus HomeCare (ADUS)AdaptHealth (AHCO)BrightSpring Health Services (BTSGU)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on CHE
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.